Publication: SEOM clinical guideline thyroid cancer (2019).
dc.contributor.author | Gallardo, E | |
dc.contributor.author | Medina, J | |
dc.contributor.author | Sánchez, J C | |
dc.contributor.author | Viúdez, A | |
dc.contributor.author | Grande, E | |
dc.contributor.author | Porras, I | |
dc.contributor.author | Ramón Y Cajal, T | |
dc.contributor.author | Trigo, J | |
dc.contributor.author | Iglesias, L | |
dc.contributor.author | Capdevila, J | |
dc.date.accessioned | 2023-02-08T14:40:16Z | |
dc.date.available | 2023-02-08T14:40:16Z | |
dc.date.issued | 2020-01-31 | |
dc.description.abstract | Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. This guideline updates several aspects of management of thyroid cancer. | |
dc.identifier.doi | 10.1007/s12094-019-02284-8 | |
dc.identifier.essn | 1699-3055 | |
dc.identifier.pmid | 32006340 | |
dc.identifier.unpaywallURL | https://link.springer.com/content/pdf/10.1007/s12094-019-02284-8.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/15027 | |
dc.issue.number | 2 | |
dc.journal.title | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | |
dc.journal.titleabbreviation | Clin Transl Oncol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Hospital Universitario Virgen de la Victoria | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.page.number | 223-235 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Multidisciplinary | |
dc.subject | Systemic therapy | |
dc.subject | Thyroid cancer | |
dc.subject.mesh | Clinical Trials as Topic | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Medical Oncology | |
dc.subject.mesh | Practice Guidelines as Topic | |
dc.subject.mesh | Societies, Medical | |
dc.subject.mesh | Thyroid Neoplasms | |
dc.title | SEOM clinical guideline thyroid cancer (2019). | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 22 | |
dspace.entity.type | Publication |